The present disclosure relates to biosensors.
Graphene is a single-atom-thick, sp2 carbon-based material used in developing sensors and biosensors due to its remarkable electrical, optical, and mechanical properties. Graphene sensors and biosensors have been developed for highly sensitive detection of a variety of analytes, including nitric oxide, ammonia, hydrogen, glucose, and glutamate. Isolation of graphene has only recently been achieved, via epitaxial growth, chemical vapor deposition (CVD), chemical exfoliation, and mechanical exfoliation.
The present disclosure provides for a biosensor comprising a graphene electrode linked to a biosensing element by a linker, and bonded to a flexible substrate. The graphene electrode has a first end and a second end, such that the first end may be a positive terminal and the second end a negative terminal In embodiments, the biosensing element is an enzyme.
Rigid substrates of field effect transistors used in graphene biosensor construction limits the potential for wide range application of graphene biosensors. The applicant of the present disclosure has identified a need for a flexible graphene biosensor useful in healthcare, food testing, defense applications, environmental monitoring, or other fields where it is desirable to detect the presence or absence of an analyte. Due to the unique sensing properties of graphene, applicant also identified the use of graphene as a highly desirable means to develop wearable and flexible graphene biosensors that may be easily fabricated. Without limiting the embodiments of the present disclosure, applicant further determined that the controlled growth of graphene using CVD in a wafer scale on a metallic film, together with post-etching for graphene transfer, provide significant opportunities for the development of flexible graphene-based bioelectronics.
Lactate excreted in sweat and in blood is a biomarker for a variety of diagnostic purposes, such as heart failure, liver diseases, metabolic disorders, drug toxicity, and mortality in ventilated infants. Lactate in food can indicate microbial contamination, which may produce lactate fermentation. Due to the importance of detecting lactate, a variety of techniques have been investigated for its determination, including high-performance liquid chromatography, spectrophotometry, magnetic resonance spectroscopy, and amperometric biosensors based on Clark-oxygen electrodes or screen-printed electrodes. However, these methods are limited by time-consuming procedures, use of capital equipment, or the rigid nature of the devices, which are unsuitable, for example, for a variety of wearable, implantable, real-time, or on-site applications.
To address the problems identified by the applicant, the present disclosure provides for apparatuses and associated methods for making and using flexible graphene-based bioelectronics and biosensors. In embodiments, the biosensors may be bio-nanosensors.
In the following description, numerous specific details are provided for a thorough understanding of specific preferred embodiments. However, those skilled in the art will recognize that embodiments can be practiced without one or more of the specific details, or with other methods, components, materials, etc. In some cases, well-known structures, materials, or operations are not shown or described in detail in order to avoid obscuring aspects of the preferred embodiments. Furthermore, the described features, structures, or characteristics may be combined in any suitable manner in a variety of alternative embodiments. Thus, the following more detailed description of the embodiments of the present invention, as illustrated in some aspects in the drawings, is not intended to limit the scope of the invention, but is merely representative of the various embodiments of the invention.
In this specification and the claims that follow, singular forms such as “a,” “an,” and “the” include plural forms unless the content clearly dictates otherwise. All ranges disclosed herein include, unless specifically indicated, all endpoints and intermediate values. In addition, “optional”, “optionally”, or “or” refer, for example, to instances in which subsequently described circumstance may or may not occur, and include instances in which the circumstance occurs and instances in which the circumstance does not occur. The terms “one or more” and “at least one” refer, for example, to instances in which one of the subsequently described circumstances occurs, and to instances in which more than one of the subsequently described circumstances occurs.
Referring to
Referring again to
A graphene electrode 101 may have any number of graphene layers that provide the conductive properties required for embodiments of the present disclosure. The methods of constructing graphene electrodes 101 of the present disclosure may result in different numbers of graphene layers on different sections of a graphene electrode 101, and there is no requirement for uniformity of the graphene layering on graphene electrodes 101. Preferably, the number of graphene layers may be from one to six. More preferably, graphene electrodes 101 of the present disclosure may consist of four or fewer layers of graphene.
In embodiments, the biosensing element 105 may be an enzyme capable of binding to a linker 107, and also capable of interacting with an analyte 106, wherein the interaction between the analyte 106 and the biosensing element 105 provides a means to detect the presence or concentration of the analyte 106 in a sample. By way of example, the means of detection may involve a current response that arises as a result of an enzymatic reaction that occurs when the enzyme contacts the analyte. By way of further example, the biosensing element may be lactate oxidase (LOD).
In general, biosensors 100 of the present disclosure may be constructed by transferring graphene from a graphene source to a flexible substrate 102, and preparing terminals 103 and 104 of a graphene electrode 101A. Next, the graphene on the flexible substrate 102 is incubated with a linker 107A, at a suitable temperature and concentration, for a period of time sufficient to produce a linker modified graphene electrode 101B. Without limiting the invention, incubation may be for a period of about two hours, and may be carried out at room temperature. In embodiments, the linker modified graphene electrode 101B comprises a layer of linkers 107B bonded to the graphene electrode 101A. In embodiments, the linker 107 is a linker molecule. Without limiting the invention, the linker molecule may be 5 mM dimthylformamide. Next, the linker-modified graphene electrode 101B is incubated with biosensing elements 105A at a concentration and temperature sufficient to produce a layer of biosensing elements 105B covalently bound to the linker modified graphene electrode 101B. Following incubation, the linker modified graphene electrode 101B with a bound layer of biosensing element 105B may be rinsed. By way of example, the linker modified graphene electrode 101B may be incubated with 2 U μl−1 of lactate oxidase in demineralized (“DI”) water overnight at 4° C., followed by rinsing with DI water and phosphate buffered saline solution (PBS) (0.1 M, pH 7.5).
Generally, a biosensor 100 of the present disclosure may be used to determine the concentration of an analyte 106 in a sample by measuring the current response generated by the interaction of biosensing elements 105 with an analyte 106. By way of example, the interaction of the biosensing elements 105 and the analyte 106 may produce a product that generates an electrical current response in the presence of an applied voltage. In embodiments, methods of the present disclosure for sensing the presence or determining the concentration of an analyte may be carried out by contacting an enzyme-functionalized, graphene electrode 101B of a biosensor 100 with a sample, measuring an electric current response in the presence of an applied voltage, and optionally correlating the electric current response to the level of an analyte 106 in the sample. Without limiting the embodiments of the present disclosure, the sample may be blood, sweat, tears, urine, culture medium, or any other suitable biological sample, and may be obtained from an animal, human, or microbial culture.
By way of example, measurements may be conducted using Autolab PGSTAT101 and carried out while the measuring device is biased at 300 mV. The measuring device may be used in combination with tNOVA software connected with a computer via USB interface for making the electrochemical measurements. Measurements may be carried out at any suitable temperature. Preferably, measurements may be performed at room temperature ˜19° C.). To carry out measurements, a sample containing an analyte 106 is applied to a graphene electrode 101 of a biosensor 100 of the present disclosure. An electrical current response is measured and is optionally correlated to the concentration of an analyte 106 in the sample.
The following examples are illustrative of specific methods to make and use biosensors 100 of the present disclosure, and are not necessarily intended to limit the embodiments of the present disclosure.
Generally, lactate biosensors of the present disclosure may be constructed by transferring a graphene electrode 101 from a rigid substrate to a flexible substrate 102, patterning with source 103 and drain electrodes 104, and immobilizing a specific enzyme for lactate on graphene. Due to the ultrathin layer of graphene, the biosensor 100 may detect lactate sensitively and rapidly. The flexibility of the substrate further allows for detecting lactate under different mechanical conditions.
Referring to
The oxidation of H2O2 on a graphene electrode 101 generates an electrical current response proportionate to the concentration of lactate. The measured electrical current response can be used to determine the concentration of lactate.
Referring to
Referring now to
Still referring to
A potentiostat, Autolab PGSTAT101 (Metrohm USA, Riverview, Fla.) and a computer installed with Autolab NOVA software were used to measure the electrical response of the grapheme biosensor 100 under various conditions. The optical microscope was purchased from Microscopes, Inc. (Northbrook, Ill.). CVD graphene (CVD graphene on Ni film on SiO2/Si) was purchased from Graphene Supermarket (Calverton, N.Y.). PELCO Conductive Silver 187 used as the terminals for the graphene electrode was purchased from Ted Pella. Inc. (Redding, Calif.). Epoxy was purchased from Epoxies, Etc. (Cranston, R.I.). Lactate oxidase was purchased from Toyobo Co., Ltd. (Osaka, Japan). L-(+)-Lactic acid was purchased from Sigma-Aldrich, Co. (St. Louis, Mo.). Thermal release tape (Revalpha thermal release tape, No. 319Y-4MS) was purchased from Nitto Denko America, Inc. (Fremont, Calif.). Polyester (PET) film (Melinex film ST507/200) was from Dupont Teijin films (Chester, Va.). Kapton tape was purchased from SRA Soldering Products (Foxboro, Mass.). Kapton (polyimide) films, Type VN (125 μm) and Type HN (50 μm), were purchased from American Durafilm (Holliston, Mass.). 1-Pyrenebutanoic acid succinimidyl ester was purchased from Anaspec, Inc. (Fremont, Calif.). N,N-Dimethylformamide 99% (DMF) was purchased from Acros Organics (Pittsburgh, Pa.). Ferric (III) chloride (FeCl3), potassium phosphate monobasic, and potassium phosphate dibasic were from Fisher Scientific (Pittsburgh, Pa.). All the solutions were prepared in ultrapure water obtained from Barnstead NANOpure® DIamond™ Water Systems (Thermo Scientific, Asheville, N.C.).
To transfer graphene to a flexible substrate 102, a thermal release tape was attached to a CVD graphene chip (graphene on Ni/SiO2/Si). The tape adhering to the substrate was then soaked in water with a gentle ultra-sonication. After a few minutes, the tape/graphene/Ni layers on the chip were peeled off from the SiO2/Si substrate as water intervened between the Ni and SiO2. The separated tape/graphene/Ni layers were then etched in FeCl3 solution to remove the Ni layers, and the remaining graphene on thermal release tape was washed with ultrapure water and dried. This graphene was then transferred to the flexible substrate 102 by bringing the tape with graphene into contact with a flexible substrate and placing it on a hot plate at a temperature of 130° C., which is slightly hotter than the release temperature of 120° C. for the thermal release tape. Two silver-paste based terminals were used to contact the graphene electrode and were coated with epoxy for insulation in order to minimize possible interferences during sensing measurements.
Graphene films were transferred to PET substrate. After preparing the positive terminal on a first terminal 103 and a negative terminal on the second terminal 104 on opposite sides of the graphene electrode 101A, the graphene film was incubated with a 5 mM linker molecule 107A (1-pyrenebutanoic acid succinimidyl ester) in dimethylformamide (DMF) for 2 hours at room temperature followed by washing with DMF and ultrapure water. The linker-modified graphene 107B was then incubated with 2 U μl-1 of lactate oxidase at 4° C. overnight, then rinsed with ultrapure water and phosphate buffered saline solution (PBS) (0.1 M, pH 7.5).
Measurements were carried out with the measuring device biased at 300 mV. All measurements were performed at room temperature (˜19° C.). To understand the electrical behavior of a flexible biosensor when subjected to mechanical bending, the current responses of the biosensor were measured upon bending inward to angles of 0°, 45°, 90° and 180°. To facilitate electrical measurements during bending, the enzyme functionalized graphene electrode 101B on PET was placed horizontally between two stands, with external copper wire touching the terminals 103 and 104 on both sides of the graphene 101A. The graphene electrode 100 was bent at different angles by moving the two stands closer together or farther apart. Lactic acid droplets in increasing order of concentration were pipetted onto the graphene electrode strip 101B covering completely the cross section of the graphene area 101B, without contacting the silver-paste electrodes 103 and 104. Using this method, applicants were able to measure the change in current response resulting from different lactate concentrations at various bending angles.
Graphene films were successfully transferred onto different plastic substrates including Kapton films, Kapton tape and thermal release tape. The transfer process for these substrates was similar to that used for PET.
Referring now to
Referring now to
In embodiments, the present disclosure provides for a biosensor useful as a wearable sensor. Flexible graphene biosensors of the present disclosure may be highly sensitive. Although sensitivity reduces significantly with increased bending angles and the number of times the sensor is bent, the sensor is still able to detect low concentrations of lactate sensitively and rapidly under different mechanical conditions. The sensor is suitable for use in a variety of wearable applications, including, but not limited to, monitoring lactate on skin.
Referring now to
Referring now to
Referring now to
Referring now to
It will be appreciated that several of the above-disclosed and other features and functions, or alternatives thereof, may be desirably combined into many other different systems or applications. Also, various presently unforeseen or unanticipated alternatives, modifications, variations or improvements therein may be subsequently made by those skilled in the art, and are also intended to be encompassed by the following claims.
This application claims benefit, under 35 U.S.C. §119(e), to U.S. provisional application No. 61/615,737, for “Flexible Graphene Sensor,” filed on Mar. 26, 2012, the entire contents of which are hereby incorporated by reference herein.
Number | Date | Country | |
---|---|---|---|
61615737 | Mar 2012 | US |